These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


123 related items for PubMed ID: 6811281

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. The effect of dibromo-dulcitol and dianhydro-dulcitol (galactitol) on RNA synthesis in ascites tumor cells.
    Fónagy A, Jeney A, Szamos J, Institóris L, Hidvégi EJ.
    Acta Biochim Biophys Acad Sci Hung; 1981; 16(3-4):151-62. PubMed ID: 6182726
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. The carcinogenic properties of some of the principal drugs used in clinical cancer chemotherapy.
    Weisburger JH, Griswold DP, Prejean JD, Casey AE, Wood HB, Weisburger EK.
    Recent Results Cancer Res; 1975; (52):1-17. PubMed ID: 138176
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Biological activity of bacterial lectins and their molecular complexes with heterocyclic bis-adducts.
    Welchinskaya HV, Piecuszak B, Kovalenko EA, Sharykina NI, Getman KI, Podgorsky VS.
    Mikrobiol Z; 2003; 65(5):20-5. PubMed ID: 14723158
    [Abstract] [Full Text] [Related]

  • 29. [Comparative study of cyclophosphamide, ifosfamide and trofosfamide on Walker-256 carcinosarcoma in embryonated chicken eggs].
    Norpoth K, Witting U, Rauen HM.
    Arzneimittelforschung; 1974 Jan; 24(1):86-9. PubMed ID: 4406116
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Phase II study of dibromodulcitol in colorectal, kidney, and other carcinomas.
    Mischler NE, Tormey DC, Klotz J, Borden EC, Ramirez G, Banerjee TK, Carr RM, Zaentz SD, Graf J.
    Cancer Clin Trials; 1981 Jan; 4(4):407-10. PubMed ID: 7318122
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Antitumor activity of 1-nitro-9-aminoacridines including nitracrine against some ascitic experimental tumors.
    Mazerska Z, Lukowicz J, Konopa J.
    Arzneimittelforschung; 1990 Apr; 40(4):472-7. PubMed ID: 2357249
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.